Coya Therapeutics (NASDAQ:COYA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Coya Therapeutics (COYA) operate in?

Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Coya Therapeutics Stock (NASDAQ: COYA) stock price, news, charts, stock research, profile.

Open	$5.76
Close	-
Volume / Avg.	15.82K / 87.96K
Day Range	$5.59 - $5.87
52 Wk Range	4.75 - 10.69
Market Cap	$96.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	1.21%
Days to Cover	2.9

Recent News

Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study

Coya Therapeutics reports mixed data from Phase 2 study of low-dose IL-2 in Alzheimer's, showing safety and potential cognitive benefits in q4wks regimen.

Vandana Singh

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases

Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.76
Close	-
Volume / Avg.	15.82K / 87.96K
Day Range	$5.59 - $5.87
52 Wk Range	4.75 - 10.69
Market Cap	$96.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	1.21%
Days to Cover	2.9

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Coya Therapeutics (COYA) stock?

You can purchase shares of Coya Therapeutics (NASDAQ:COYA) through any online brokerage.

View our list of the best stock brokerages

Who are Coya Therapeutics (COYA) competitors?

Other companies in Coya Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM) and Century Therapeutics (NASDAQ:IPSC).

What is the forecast, or price target, for Coya Therapeutics (COYA) stock?

Coya Therapeutics has a consensus price target of $18.00.

What is the current price for Coya Therapeutics (COYA)?

The stock price for Coya Therapeutics (NASDAQ: COYA) is $5.75 last updated December 16, 2024 at 11:34 AM EST.

Does Coya Therapeutics (COYA) pay a dividend?

There are no upcoming dividends for Coya Therapeutics.

When is Coya Therapeutics (NASDAQ:COYA) reporting earnings?

Coya Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Coya Therapeutics (COYA) going to split?

There is no upcoming split for Coya Therapeutics.

What sector and industry does Coya Therapeutics (COYA) operate in?

Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Coya Therapeutics

Coya Therapeutics (COYA) Forecast